
Lighting Science Group Corporation designs, develops, and markets general illumination products that use light emitting diodes (LEDs) as their light source for retailers and original equipment manufacturers in the United States. It offers a range of LED retrofit lamps to fit into existing light fixtures as replacements for traditional incandescent, compact fluorescent, and halogen lamps; and LED luminaires comprising FreeLED, a street lighting solution that uses solar energy as its power source. The company also provides biological lighting products, which include Good Night and Good Day circadian replacement lamps, VividGro grow light product, MyNature Coastal lamps and outdoor luminaires, and MyNature Grow lighting lamps and high bay luminaires. It serves Residential and office, Retail and hospitality, Government-owned and private infrastructure, and School and university markets through branded and co-branded private label programs, direct sales force, distributors, and independent sales agents. Lighting Science Group Corporation was incorporated in 1988 and is headquartered in West Warwick, Rhode Island.
Lighting Science Group Corporation trades as LSCG on OTC. The company is classified in Industrials / Electrical Equipment & Parts and reports in USD.
The current profile places the business in Electrical Equipment & Parts. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $52.70M of revenue and -$15.60M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Lighting Science Group Corporation can be compared against peers such as Beacon Redevelopment Industrial Corporation, Blue Water Petroleum Corp., Enable IPC Corporation, Innovest Global, Inc., Lithium Technology Corporation, Scorpex, Inc..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $2,178, beta of -0.21, and return on equity of +60.0%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
LSCG currently shows total debt of $34.64M and beta of -0.21. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.lsgc.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.